United States

BMS to spend $250M to expand biologics facility, create 350 jobs

Friday, April 12, 2013 10:43 AM

Bristol-Myers Squibb (BMS) is planning a $250 million expansion of its large-scale biologics manufacturing facility in Devens, Mass. The expansion will introduce biologics development and clinical trial manufacturing capabilities to the site, while adding approximately 350 employees to the Devens workforce over time.

More... »

Bourne Partners, Covis Pharma acquire U.S. rights for five drugs from Sanofi

Monday, April 8, 2013 11:34 AM

Covis Pharma, a Switzerland-based specialty pharmaceutical company, has formed an agreement with Sanofi-Aventis and certain affiliates to acquire full commercial rights for Nilandron (nilutamide), Plaquenil (hydroxychloroquine), Rilutek (riluzole), Uroxatral (alfuzosin hydrochloride) and Kayexalate (sodium polystyrene sulfate) in the U.S.  

More... »

TranScrip Partners announce U.S. expansion

Monday, April 8, 2013 09:39 AM

TranScrip Partners, a U.K.-based CRO, has created a U.S. office. The U.S. branch of TranScrip Partners will be led by Glenn Tillotson, a pharmaceutical expert with 25 years' industry experience and a successful track record in drug development and life cycle management.

More... »

ActiGraph releases API supporting actigraphy data collection

Monday, April 8, 2013 08:00 AM

ActiGraph, a provider of objective physical activity and sleep/wake monitoring solutions, has released an Application Programming Interface (API) to its popular ActiLife analysis software.

More... »

Regeneron Pharmaceuticals to expand headquarters, create 400 jobs

Friday, April 5, 2013 11:07 AM

Regeneron Pharmaceuticals, a science-based biopharmaceutical company based in Tarrytown, N.Y., will expand its corporate headquarters and create more than 400 new high-skill jobs. 

More... »

MedImmune aquires Alphacore Pharma

Wednesday, April 3, 2013 02:20 PM

MedImmune, AstraZeneca’s global biologics R&D arm, has acquired AlphaCore Pharma, an Ann Arbor, Mich.-based biotechnology company focused on the development of ACP-501, a recombinant human lecithin-cholesterol acyltransferase (LCAT) enzyme.

More... »

FDA approves Janssen’s Invokana for type 2 diabetes

Monday, April 1, 2013 02:15 PM

The FDA has approved Janssen Pharmaceuticals’ Invokana (canagliflozin) for the treatment of adults with type 2 diabetes.

More... »

PPD expands cGMP cell-based assay laboratory

Friday, March 29, 2013 02:14 PM

Pharmaceutical Product Development (PPD), a global CRO, is expanding itscGMP cell-based assay laboratory in Middleton, Wis., to meet the growing needs of clients seeking to validate bioassays for product release and stability testing of biological products, both as novel drugs and as biosimilars.

More... »

GSK, Texas A&M to establish influenza vaccine facility in Texas

Friday, March 29, 2013 11:20 AM

The U.S. Department of Health and Human Services (DHHS) has approved GlaxoSmithKline’s (GSK) and The Texas A&M University System’s proposal to establish a $91 million influenza-vaccines manufacturing facility as the anchor of the Center for Innovation in Advanced Development and Manufacturing (CIADM) in Bryan-College Station, Texas.

More... »

Soligenix receives IND clearance from FDA for SGX942 in oral mucositis

Wednesday, March 27, 2013 08:59 AM

The FDA cleared the Soligenix’s Investigational New Drug (IND) application for SGX942 for the treatment of oral mucositis resulting from radiation and/or chemotherapy treatment in head and neck cancer patients.

More... »